OraSure Technologies, Inc. (NASDAQ: OSUR) has been awarded a contract for up to $16.6 million in total funding from the U.S. Department of Health and Human Services to advance its rapid Zika tests. The rapid Zika tests utilize OraSure’s OraQuick® technology platform, which is the same proven technology used in the company’s rapid HIV, HCV, and Ebola test kits. Read more via Lehigh Valley Business and StreetInsider.com.
Client & Alumni News
OraSure Technologies Awarded $16.6M for Rapid Zika Tests
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.